WVE
Wave Life Sciences Ltd
4.30$
-2.2%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8,241.4% | -2,146.3% | -2,258.9% | -158.6% | -1,177.7% | -577.7% | -217.2% | -3,501.8% | -17.1% | -139.4% | -438.8% | |
| – | 390.8% | 52.8% | 58.2% | 38.7% | 57.6% | 49.7% | 24.0% | 277.2% | 8.1% | 8.0% | 20.7% | |
| – | 2,647.4% | 461.1% | 327.8% | 108.2% | 122.1% | 71.2% | 40.1% | 471.2% | 8.6% | 12.1% | 58.4% | |
| – | 2,860.5% | 431.2% | 449.3% | 108.5% | 122.1% | 71.2% | 40.1% | 471.5% | – | – | – | |
| – | 1,270.4% | 1,091.4% | -8.1% | 710.3% | -145.8% | 48.1% | 17.1% | 184.2% | 16.8% | -70.0% | -39.6% | |
| – | 1,221.7% | 374.9% | 509.9% | 68.9% | 24.5% | 6.7% | 1.4% | 37.3% | 1.0% | 0.9% | 1.7% | |
| – | -1,913.8% | -549.6% | -510.2% | -68.9% | -24.5% | -6.7% | -1.4% | -34.4% | -1.0% | -0.9% | -1.7% | |
| – | 74,391.4% | 2,020.2% | 0.0% | – | – | – | – | – | – | – | – | |
| – | 115,530.9% | 2,037.6% | 2,549.6% | 451.7% | 1,028.6% | 471.5% | 136.3% | 1,811.0% | – | – | – | |
| – | -82.9% | -4.2% | -1.7% | -0.1% | – | – | – | – | – | – | – | |
| – | 115,521.7% | 1,961.0% | 2,547.9% | 451.6% | 1,028.6% | 769.7% | 136.3% | 1,841.3% | 117.0% | 234.4% | 1,142.7% | |
| – | 105,376.3% | -735.8% | -210.3% | 224.3% | -172.9% | 186.0% | -82.8% | -1,700.7% | 98.8% | 94.0% | 702.2% | |
| – | -9,463.2% | -2,521.1% | -2,768.8% | -227.6% | -1,202.2% | -584.4% | -218.6% | -3,539.1% | -18.1% | -140.3% | -438.8% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.